Thyroid cancer, nonmedullary, 5

Summary

Nonmedullary thyroid cancer (NMTC) comprises cancer of follicular cell origin and accounts for more than 95% of all cases of thyroid cancer. Familial NMTC accounts for 3 to 9% of all cases of thyroid cancer and has an autosomal dominant mode of inheritance. Most cases of familial NMTC are papillary thyroid cancer (PTC), which is the most common type of thyroid cancer (summary by Gara et al., 2015). For a general phenotypic description and a discussion of genetic heterogeneity of NMTC, see NMTC1 (188550). [from OMIM]

Available tests

5 tests are in the database for this condition.

Clinical tests (5 available)

Molecular Genetics Tests

Genes See tests for all associated and related genes

Associated genes Help
Genes reported to contribute to the condition.

HABP2
14 tests
Also known as: FSAP, HABP, HGFAL, NMTC5, PHBP, HABP2
Summary: hyaluronan binding protein 2

Imported from Human Phenotype Ontology (HPO)

Show all Hide all

Neoplasm
- Familial nonmedullary thyroid carcinoma
  Familial nonmedullary thyroid carcinoma
  - MedGen UID: 502247
  - Concept ID: C3501843
  - Finding: Neoplastic Process
  Neoplasm
  See: Feature record | Search on this feature

Reviews

Clinical resources

Practice guidelines

NICE, 2022
UK NICE Guideline NG230, Thyroid cancer: assessment and management

Molecular resources

Consumer resources

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.